CKAP2L, as an Independent Risk Factor, Closely Related to the Prognosis of Glioma

Figure 7

CKAP2L expression and clinical effect on glioma patients: (a) CKAP2L expression in normal brain tissues and glioma tissues; (b) CKAP2L expression in different glioma cell lines; (c) the survival curve of high CKAP2L expression in low-grade glioma patients; (d) the survival curve of high CKAP2L expression in high-grade glioma patients.

(a)

(b)

(c)

(d)